A polymorphism in CCR1/CCR3 is associated with narcolepsy

Brain, Behavior, and Immunity

Volumn 49, Issue , 2015, Pages 148-155

  Toyoda, Hiromi ^a   Miyagawa, Taku ^a   Koike, Asako ^b   Kanbayashi, Takashi ^c   Imanishi, Aya ^c   Sagawa, Yohei ^c   Kotorii, Nozomu ^d,e   Kotorii, Tatayu ^e   Hashizume, Yuji ^d   Ogi, Kimihiro ^d   Hiejima, Hiroshi ^d   Kamei, Yuichi ^f   Hida, Akiko ^f   Miyamoto, Masayuki ^g   Imai, Makoto ^h   Fujimura, Yota ⁱ   Tamura, Yoshiyuki ⁱ   Ikegami, Azusa ^j   Wada, Yamato ^k   Moriya, Shunpei ^l   Furuya, Hirokazu ^m   Takeuchi, Masaki ^n,o   Kirino, Yohei ^n,o   Meguro, Akira ⁿ   Remmers, Elaine F ^o   Kawamura, Yoshiya ^p   Otowa, Takeshi ^a   Miyashita, Akinori ^q   Kashiwase, Koichi ^r   Khor, Seik Soon ^a   Yamasaki, Maria ^a   Kuwano, Ryozo ^q   Sasaki, Tsukasa ^s   Ishigooka, Jun ^l   Kuroda, Kenji ^k   Kume, Kazuhiko ^j,t,u   Chiba, Shigeru ⁱ   Yamada, Naoto ^h   Okawa, Masako ^h,v,x   Hirata, Koichi ^g   Mizuki, Nobuhisa ⁿ   Uchimura, Naohisa ^d   Shimizu, Tetsuo ^c   Inoue, Yuichi ^w,x   Honda, Yutaka ^w   Mishima, Kazuo ^f   Honda, Makoto ^w,y   Tokunaga, Katsushi ^a   more..

^a UNIVERSITY OF TOKYO   (Japan)

^b HITACHI LTD   (Japan)

^c AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e Kotorii Isahaya Hospital   (Japan)

^f NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

^g DOKKYO MEDICAL UNIVERSITY   (Japan)

^h SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

ⁱ ASAHIKAWA MEDICAL COLLEGE   (Japan)

^j Kuwamizu Hospital   (Japan)

^k Hannan Hospital   (Japan)

^l TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^m National Hospital Organization Omuta Hospital   (Japan)

ⁿ YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^o NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^p Department of Psychiatry   (Japan)

^q Niigata University   (Japan)

^r Japanese Red Cross Kanto Koshinetsu Block Blood Center   (Japan)

^s UNIVERSITY OF TOKYO   (Japan)

^t KUMAMOTO UNIVERSITY   (Japan)

^u NAGOYA CITY UNIVERSITY   (Japan)

^v The Japan Foundation   (Japan)

^w NEUROPSYCHIATRIC RESEARCH INSTITUTE   (Japan)

^x TOKYO MEDICAL UNIVERSITY   (Japan)

^y TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

more..

Author keywords

Chemokine receptor; Complex traits; Genome wide association study; Microglia; Narcolepsy; Neuroinflammation

Indexed keywords

CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR3; HLA DPB1 ANTIGEN; MESSENGER RNA; CCR1 PROTEIN, HUMAN; CCR3 PROTEIN, HUMAN;

ALLELE; ARTICLE; BLOOD SAMPLING; CCR1 GENE; CCR3 GENE; CELL MIGRATION; CHEMOTAXIS; CONTROLLED STUDY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HETEROZYGOTE; HLA DQB1 GENE; HUMAN; HUMAN CELL; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; MONOCYTE; NARCOLEPSY; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; ASIAN CONTINENTAL ANCESTRY GROUP; GENETICS; GENOME-WIDE ASSOCIATION STUDY; JAPAN;

ASIAN CONTINENTAL ANCESTRY GROUP; GENOME-WIDE ASSOCIATION STUDY; HUMANS; JAPAN; NARCOLEPSY; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CCR1; RECEPTORS, CCR3;

EID: 84940597465     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2015.05.003     Document Type: Article

References (55)

1. Balding D.J. A tutorial on statistical methods for population association studies. Nat. Rev. Genet. 2006, 7:781-791.
2. Bhutani N., Brady J.J., Damian M., Sacco A., Corbel S.Y., Blau H.M. Reprogramming towards pluripotency requires AID-dependent DNA demethylation. Nature 2010, 463:1042-1047.
3. Cardona A.E., Pioro E.P., Sasse M.E., Kostenko V., Cardona S.M., Dijkstra I.M., Huang D., Kidd G., Dombrowski S., Dutta R., Lee J.C., Cook D.N., Jung S., Lira S.A., Littman D.R., Ransohoff R.M. Control of microglial neurotoxicity by the fractalkine receptor. Nat. Neurosci. 2006, 9:917-924.
4. Cartier L., Hartley O., Dubois-Dauphin M., Krause K.H. Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases. Brain Res. Brain Res. Rev. 2005, 48:16-42.
5. Chemelli R.M., Willie J.T., Sinton C.M., Elmquist J.K., Scammell T., Lee C., Richardson J.A., Williams S.C., Xiong Y., Kisanuki Y., Fitch T.E., Nakazato M., Hammer R.E., Saper C.B., Yanagisawa M. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 1999, 98:437-451.
6. Cho J.H., Gregersen P.K. Genomics and the multifactorial nature of human autoimmune disease. N. Engl. J. Med. 2011, 365:1612-1623.
7. Dalal J., Roh J.H., Maloney S.E., Akuffo A., Shah S., Yuan H., Wamsley B., Jones W.B., de Guzman Strong C., Gray P.A., Holtzman D.M., Heintz N., Dougherty J.D. Translational profiling of hypocretin neurons identifies candidate molecules for sleep regulation. Genes Dev. 2013, 27:565-578.
8. Dauvilliers Y., Jaussent I., Lecendreux M., Scholz S., Bayard S., Cristol J.P., Blain H., Dupuy A.M. Cerebrospinal fluid and serum cytokine profiles in narcolepsy with cataplexy: a case-control study. Brain Behav. Immun. 2014, 37:260-266.
9. Eltayeb S., Berg A.L., Lassmann H., Wallstrom E., Nilsson M., Olsson T., Ericsson-Dahlstrand A., Sunnemark D. Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: insight into mechanisms of MOG-induced EAE. J. Neuroinflammation 2007, 4:14.
10. Faraco J., Lin L., Kornum B.R., Kenny E.E., Trynka G., Einen M., Rico T.J., Lichtner P., Dauvilliers Y., Arnulf I., Lecendreux M., Javidi S., Geisler P., Mayer G., Pizza F., Poli F., Plazzi G., Overeem S., Lammers G.J., Kemlink D., Sonka K., Nevsimalova S., Rouleau G., Desautels A., Montplaisir J., Frauscher B., Ehrmann L., Hogl B., Jennum P., Bourgin P., Peraita-Adrados R., Iranzo A., Bassetti C., Chen W.M., Concannon P., Thompson S.D., Damotte V., Fontaine B., Breban M., Gieger C., Klopp N., Deloukas P., Wijmenga C., Hallmayer J., Onengut-Gumuscu S., Rich S.S., Winkelmann J., Mignot E. ImmunoChip study implicates antigen presentation to T cells in narcolepsy. PLoS Genet. 2013, 9:e1003270.
11. Haga H., Yamada R., Ohnishi Y., Nakamura Y., Tanaka T. Gene-based SNP discovery as part of the Japanese Millennium Genome Project: identification of 190,562 genetic variations in the human genome single-nucleotide polymorphism. J. Hum. Genet. 2002, 47:605-610.
12. Hallmayer J., Faraco J., Lin L., Hesselson S., Winkelmann J., Kawashima M., Mayer G., Plazzi G., Nevsimalova S., Bourgin P., Hong S.C., Honda Y., Honda M., Hogl B., Longstreth W.T., Montplaisir J., Kemlink D., Einen M., Chen J., Musone S.L., Akana M., Miyagawa T., Duan J., Desautels A., Erhardt C., Hesla P.E., Poli F., Frauscher B., Jeong J.H., Lee S.P., Ton T.G., Kvale M., Kolesar L., Dobrovolna M., Nepom G.T., Salomon D., Wichmann H.E., Rouleau G.A., Gieger C., Levinson D.F., Gejman P.V., Meitinger T., Young T., Peppard P., Tokunaga K., Kwok P.Y., Risch N., Mignot E. Narcolepsy is strongly associated with the T-cell receptor alpha locus. Nat. Genet. 2009, 41:708-711.
13. Han F., Faraco J., Dong X.S., Ollila H.M., Lin L., Li J., An P., Wang S., Jiang K.W., Gao Z.C., Zhao L., Yan H., Liu Y.N., Li Q.H., Zhang X.Z., Hu Y., Wang J.Y., Lu Y.H., Lu C.J., Zhou W., Hallmayer J., Huang Y.S., Strohl K.P., Pollmacher T., Mignot E. Genome wide analysis of narcolepsy in China implicates novel immune loci and reveals changes in association prior to versus after the 2009 H1N1 influenza pandemic. PLoS Genet. 2013, 9:e1003880.
14. Hara J., Beuckmann C.T., Nambu T., Willie J.T., Chemelli R.M., Sinton C.M., Sugiyama F., Yagami K., Goto K., Yanagisawa M., Sakurai T. Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron 2001, 30:345-354.
15. Hogan D., Hutton L.A., Smith E.M., Opp M.R. Beta (CC)-chemokines as modulators of sleep: implications for HIV-induced alterations in arousal state. J. Neuroimmunol. 2001, 119:317-326.
16. Howie B.N., Donnelly P., Marchini J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet. 2009, 5:e1000529.
17. Juji T., Satake M., Honda Y., Doi Y. HLA antigens in Japanese patients with narcolepsy. All the patients were DR2 positive. Tissue Antigens 1984, 24:316-319.
18. Khan M.Z., Brandimarti R., Shimizu S., Nicolai J., Crowe E., Meucci O. The chemokine CXCL12 promotes survival of post mitotic neurons by regulating Rb protein. Cell Death Differ. 2008, 15:1663-1672.
19. Khatami R., Maret S., Werth E., Retey J., Schmid D., Maly F., Tafti M., Bassetti C.L. Monozygotic twins concordant for narcolepsy-cataplexy without any detectable abnormality in the hypocretin (orexin) pathway. Lancet 2004, 363:1199-1200.
20. Kheirandish-Gozal L., Wang Y., Duggan R.C., Harshan Vardhan S., Tan H.L., Molero Ramirez H., Khalyfa A., Bhattacharjee R., Bandla H.P., Gozal D. Nitric oxide production by monocytes in children with OSA and endothelial dysfunction. Clin. Sci. (Lond.) 2014, 127:323-330.
21. Kirino Y., Bertsias G., Ishigatsubo Y., Mizuki N., Tugal-Tutkun I., Seyahi E., Ozyazgan Y., Sacli F.S., Erer B., Inoko H., Emrence Z., Cakar A., Abaci N., Ustek D., Satorius C., Ueda A., Takeno M., Kim Y., Wood G.M., Ombrello M.J., Meguro A., Gul A., Remmers E.F., Kastner D.L. Genome-wide association analysis identifies new susceptibility loci for Behcet's disease and epistasis between HLA-B*51 and ERAP1. Nat. Genet. 2013, 45:202-207.
22. Koizumi S., Ohsawa K., Inoue K., Kohsaka S. Purinergic receptors in microglia: functional modal shifts of microglia mediated by P2 and P1 receptors. Glia 2013, 61:47-54.
23. Kornum B.R., Faraco J., Mignot E. Narcolepsy with hypocretin/orexin deficiency, infections and autoimmunity of the brain. Curr. Opin. Neurobiol. 2011, 21:897-903.
24. Kornum B.R., Kawashima M., Faraco J., Lin L., Rico T.J., Hesselson S., Axtell R.C., Kuipers H., Weiner K., Hamacher A., Kassack M.U., Han F., Knudsen S., Li J., Dong X., Winkelmann J., Plazzi G., Nevsimalova S., Hong S.C., Honda Y., Honda M., Hogl B., Ton T.G., Montplaisir J., Bourgin P., Kemlink D., Huang Y.S., Warby S., Einen M., Eshragh J.L., Miyagawa T., Desautels A., Ruppert E., Hesla P.E., Poli F., Pizza F., Frauscher B., Jeong J.H., Lee S.P., Strohl K.P., Longstreth W.T., Kvale M., Dobrovolna M., Ohayon M.M., Nepom G.T., Wichmann H.E., Rouleau G.A., Gieger C., Levinson D.F., Gejman P.V., Meitinger T., Peppard P., Young T., Jennum P., Steinman L., Tokunaga K., Kwok P.Y., Risch N., Hallmayer J., Mignot E. Common variants in P2RY11 are associated with narcolepsy. Nat. Genet. 2011, 43:66-71.
25. Kreutzberg G.W. Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 1996, 19:312-318.
26. Lim A.S., Scammell T.E. The trouble with Tribbles: do antibodies against TRIB2 cause narcolepsy?. Sleep 2010, 33:857-858.
27. Lonsdale J, T.J., Salvatore M, Phillips R, Lo E, Shad S, Hasz R, Walters G, Garcia F, Young N, Foster B, Moser M, Karasik E, Gillard B, Ramsey K, Sullivan S, Bridge J, Magazine H, Syron J, Fleming J, Siminoff L, Traino H, Mosavel M, Barker L, Jewell S, Rohrer D, Maxim D, Filkins D, Harbach P, Cortadillo E, Berghuis B, Turner L, Hudson E, Feenstra K, Sobin L, Robb J, Branton P, Korzeniewski G, Shive C, Tabor D, Qi L, Groch K, Nampally S, Buia S, Zimmerman A, Smith A, Burges R, Robinson K, Valentino K, Bradbury D, Cosentino M, Diaz-Mayoral N, Kennedy M, Engel T, Williams P, Erickson K, Ardlie K, Winckler W, Getz G, DeLuca D, MacArthur D, Kellis M, Thomson A, Young T, Gelfand E, Donovan M, Grant G, Mash D, Marcus Y, Basile M, Liu J, Zhu J, Tu Z, Cox NJ, Nicolae DL, Gamazon ER, Kyung H, Konkashbaev A, Pritchard J, Stevens M, Flutre T, Wen X, Dermitzakis T, Lappalainen T, Guigo R, Monlong J, Sammeth M, Koller D, Battle A, Mostafavi S, McCarthy M, Rivas M, Maller J, Rusyn I, Nobel A, Wright F, Shabalin A, Feolo M, Sharopova N, Sturcke A, Paschal J, Anderson JM, Wilder EL, Derr LK, Green ED, Struewing JP, Temple G, Volpi S, Boyer JT, Thomson EJ, Guyer MS, Ng C, Abdallah A, Colantuoni D, Insel TR, Koester SE, Little AR, Bender PK, Lehner T, Yao Y, Compton CC, Vaught JB, Sawyer S, Lockhart NC, Demchok J, Moore HF., 2013. The Genotype-Tissue Expression (GTEx) project. Nat Genet 45, 580-585.
28. Macintyre G., Bailey J., Haviv I., Kowalczyk A. Is-rSNP: a novel technique for in silico regulatory SNP detection. Bioinformatics 2010, 26:i524-i530.
29. Maurovich-Horvat E., Keckeis M., Lattova Z., Kemlink D., Wetter T.C., Schuld A., Sonka K., Pollmacher T. Hypothalamo-pituitary-adrenal axis, glucose metabolism and TNF-alpha in narcolepsy. J. Sleep Res. 2014.
30. Meucci O., Fatatis A., Simen A.A., Miller R.J. Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survival. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:8075-8080.
31. Mignot E. Genetic and familial aspects of narcolepsy. Neurology 1998, 50:S16-S22.
32. Mignot E., Lammers G.J., Ripley B., Okun M., Nevsimalova S., Overeem S., Vankova J., Black J., Harsh J., Bassetti C., Schrader H., Nishino S. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch. Neurol. 2002, 59:1553-1562.
33. Mignot E., Lin L., Rogers W., Honda Y., Qiu X., Lin X., Okun M., Hohjoh H., Miki T., Hsu S., Leffell M., Grumet F., Fernandez-Vina M., Honda M., Risch N. Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups. Am. J. Hum. Genet. 2001, 68:686-699.
34. Miller A.L., Gerard C., Schaller M., Gruber A.D., Humbles A.A., Lukacs N.W. Deletion of CCR1 attenuates pathophysiologic responses during respiratory syncytial virus infection. J. Immunol. 2006, 176:2562-2567.
35. Miller E., Andrews N., Stellitano L., Stowe J., Winstone A.M., Shneerson J., Verity C. Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine: retrospective analysis. BMJ 2013, 346:f794.
36. Miyagawa T., Kawashima M., Nishida N., Ohashi J., Kimura R., Fujimoto A., Shimada M., Morishita S., Shigeta T., Lin L., Hong S.C., Faraco J., Shin Y.K., Jeong J.H., Okazaki Y., Tsuji S., Honda M., Honda Y., Mignot E., Tokunaga K. Variant between CPT1B and CHKB associated with susceptibility to narcolepsy. Nat. Genet. 2008, 40:1324-1328.
37. Ness T.L., Carpenter K.J., Ewing J.L., Gerard C.J., Hogaboam C.M., Kunkel S.L. CCR1 and CC chemokine ligand 5 interactions exacerbate innate immune responses during sepsis. J. Immunol. 2004, 173:6938-6948.
38. Nishida N., Tanabe T., Takasu M., Suyama A., Tokunaga K. Further development of multiplex single nucleotide polymorphism typing method, the DigiTag2 assay. Anal. Biochem. 2007, 364:78-85.
39. Nishino S., Ripley B., Overeem S., Lammers G.J., Mignot E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 2000, 355:39-40.
40. Okun M.L., Giese S., Lin L., Einen M., Mignot E., Coussons-Read M.E. Exploring the cytokine and endocrine involvement in narcolepsy. Brain Behav. Immun. 2004, 18:326-332.
41. Price A.L., Patterson N.J., Plenge R.M., Weinblatt M.E., Shadick N.A., Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet. 2006, 38:904-909.
42. Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M.A., Bender D., Maller J., Sklar P., de Bakker P.I., Daly M.J., Sham P.C. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 2007, 81:559-575.
43. Reaux-Le Goazigo A., Van Steenwinckel J., Rostene W., Melik Parsadaniantz S. Current status of chemokines in the adult CNS. Prog. Neurobiol. 2013, 104:67-92.
44. Schall T.J., Proudfoot A.E. Overcoming hurdles in developing successful drugs targeting chemokine receptors. Nat. Rev. Immunol. 2011, 11:355-363.
45. Tabuchi S., Tsunematsu T., Black S.W., Tominaga M., Maruyama M., Takagi K., Minokoshi Y., Sakurai T., Kilduff T.S., Yamanaka A. Conditional ablation of orexin/hypocretin neurons: a new mouse model for the study of narcolepsy and orexin system function. J. Neurosci. 2014, 34:6495-6509.
46. Takeshita Y., Ransohoff R.M. Inflammatory cell trafficking across the blood-brain barrier: chemokine regulation and in vitro models. Immunol. Rev. 2012, 248:228-239.
47. Tanaka S., Honda M., Toyoda H., Kodama T. Increased plasma IL-6, IL-8, TNF-alpha, and G-CSF in Japanese narcolepsy. Hum. Immunol. 2014.
48. Wacholder S., Chanock S., Garcia-Closas M., El Ghormli L., Rothman N. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J. Natl. Cancer Inst. 2004, 96:434-442.
49. Wainwright D.A., Xin J., Mesnard N.A., Beahrs T.R., Politis C.M., Sanders V.M., Jones K.J. Exacerbation of facial motoneuron loss after facial nerve axotomy in CCR3-deficient mice. ASN Neuro. 2009, 1:e00024.
50. White G.E., Iqbal A.J., Greaves D.R. CC chemokine receptors and chronic inflammation-therapeutic opportunities and pharmacological challenges. Pharmacol. Rev. 2013, 65:47-89.
51. Wijnans L., Lecomte C., de Vries C., Weibel D., Sammon C., Hviid A., Svanstrom H., Molgaard-Nielsen D., Heijbel H., Dahlstrom L.A., Hallgren J., Sparen P., Jennum P., Mosseveld M., Schuemie M., van der Maas N., Partinen M., Romio S., Trotta F., Santuccio C., Menna A., Plazzi G., Moghadam K.K., Ferro S., Lammers G.J., Overeem S., Johansen K., Kramarz P., Bonhoeffer J., Sturkenboom M.C. The incidence of narcolepsy in Europe: before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns. Vaccine 2013, 31:1246-1254.
52. Yamaguchi-Kabata Y., Nakazono K., Takahashi A., Saito S., Hosono N., Kubo M., Nakamura Y., Kamatani N. Japanese population structure, based on SNP genotypes from 7003 individuals compared to other ethnic groups: effects on population-based association studies. Am. J. Hum. Genet. 2008, 83:445-456.
53. Yang I., Han S.J., Kaur G., Crane C., Parsa A.T. The role of microglia in central nervous system immunity and glioma immunology. J. Clin. Neurosci. 2010, 17:6-10.
54. Yang T.P., Beazley C., Montgomery S.B., Dimas A.S., Gutierrez-Arcelus M., Stranger B.E., Deloukas P., Dermitzakis E.T. Genevar: a database and Java application for the analysis and visualization of SNP-gene associations in eQTL studies. Bioinformatics 2010, 26:2474-2476.
55. Yao H., Peng F., Dhillon N., Callen S., Bokhari S., Stehno-Bittel L., Ahmad S.O., Wang J.Q., Buch S. Involvement of TRPC channels in CCL2-mediated neuroprotection against tat toxicity. J. Neurosci. 2009, 29:1657-1669.